Latest News

Endlich schmerzfrei

Mainstay Medical gibt die Ernennung von Jeffrey Dunn und Eric Major als neue Vorstandsmitglieder bekannt

Mainstay Announces Limited Commercial Launch of ReActiv8® in the U.S.

Die neue Version von MainstayMedical.com

Veröffentlichung der 2-Jahres Daten zur klinischen Studie ReActiv8-B

You just clicked on a link to go to another Mainstay Medical ("Mainstay") website that is different from your current website, which is specifically intended for your country/region.  Please note there may be important differences on Mainstay websites designed for other countries/regions, including information about product (ReActiv8) indication and use, regulatory approval, healthcare practice standards, and data protection laws, among other things.  Do you still wish to continue to the different site?